CASE REPORT article
Front. Cardiovasc. Med.
Sec. Pediatric Cardiology
Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1611156
Simultaneous Covered Stenting for Aortic Coarctation and Significant PDA in Low and Very Low Birth Weight Preterm Infants: Technical Insights from Two Cases
Provisionally accepted
- 1Department of Pediatric Cardiology, University Hospital Bonn, Bonn, Germany
- 2University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany
- 3Asklepios Klinik Altona, Hamburg, Hamburg, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background. To the best of our knowledge, no study to date has reported the use of covered stents in preterm and low weight (LW) preterm babies for the combined treatment of aortic coarctation (CoA) and persistent patent ductus arteriosus (PDA) in these critically ill patients. Patients and methods. In 2023, two premature infants with isolated critical CoA and a window-shaped PDA were treated with Biotronik PK Papyrus covered coronary stents. The indications for intervention in the first patient included a significant, short PDA with respiratory deterioration and necrotizing enterocolitis (NEC), despite prior CoA treatment using a premounted coronary stent and ongoing ibuprofen therapy, which failed to close the PDA. The second patient presented with impaired left-ventricular (LV) function, renal insufficiency, and NEC. Echocardiography was used both to assess the outcome of the intervention and for follow-up. The patency of the PDA was documented at 12 and 24 hr postintervention. Results. Patient 1, with a gestational age (GA) of 32 weeks and a birth weight of 1,400 g, and Patient 2, with a GA) of 30 weeks and a birth weight of 1,900 g, underwent the procedure at 20 and 11 days of age, respectively. Both patients successfully received a PK Papyrus covered stent implantation. Angiographic imaging immediately following the intervention revealed evidence of a residual shunt in each patient. However, at 12 hr postprocedure, no residual PDA shunt was detected on echocardiography. Both patients underwent successful surgical repair 7 and 10 months later, with complete removal of the 15-mm stents. Conclusion. In our rare and small cohort, covered stenting for CoA and PDA proved effective and safe in low-weight and very-low-weight premature infants, improving coarctation, achieving complete PDA closure, and offering the potential for full stent removal. The small sample size reflects the cohort's critical specificity, and the findings require validation in larger populations
Keywords: severe coarctation of the aorta, prematurity, Covered coronary stent, CoA in prematurity, CaA stenting
Received: 13 Apr 2025; Accepted: 20 Aug 2025.
Copyright: © 2025 Mini, Schindle, Breuer, Mikus and Schneider. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Nathalie Mini, Department of Pediatric Cardiology, University Hospital Bonn, Bonn, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.